PierianDx had a blast with all of its customers at the Partner Sharing Network Reception we hosted during AMP 2016. We are already excited about AMP 2017. Save the date: November 17. We will be hosting another reception and would love for you to attend. We are currently selecting our venue and will send details as we get closer to the event. See you in Salt Lake City!
Register here for our reception on November 17.
At ACMG this year, PierianDx took part in the New Product Showcase highlighting the latest features to our CGW platform with version 6.0. Additionally, we premiered our new Interpretation Services which you can read about here. Thanks for making this a successful show for us. We hope to see you next year!
Accelerating Your NGS Testing Program: Examples and Case Studies
On March 9th, Clinical Genomicist Workspace user and Partner Sharing Network contributor, Dr. Nikoletta Sidiropoulos from University of Vermont Medical Center hosted a webinar with PierianDx exploring various ways clinical labs have established or expanded their NGS testing programs by implementing improved workflow and clinical integration into their organization. Dr. Sidiropoulos shared her experiences and lessons learned as she works to evolve the university’s precision medicine program. Specific examples were shared on how to improve clinical lab workflow, starting with DNA or RNA samples and ending with a report of relevant variants to assist in clinical decision-making. By the end of this webinar, participants will have some real-world examples of how to accelerate their own personalized medicine initiatives from clinical experts in the field.
NGS Roundtable: Ask the Experts about the Future of Clinical NGS Testing
This interactive roundtable discusses established and emerging regulatory, scientific, and medical topics related to next-generation sequencing in the clinical setting. An expert panel of leading pathologists, medical geneticists, and researchers will address genomic testing advances in two thematic areas: 1) scientific and clinical trends in reporting, and 2) clinical lab operations and quality management.
Topics covered by the expert panel include the importance of proficiency testing, both from the regulatory and quality perspective, and technical and clinical advances in using NGS to predict effective immunotherapy and determine tumor mutation load.